Non-Alcoholic Steatohepatitis Clinical Trials Market to 2035

blog ekledi Hobi

2026-05-21 12:26:26

Non-Alcoholic Steatohepatitis Clinical Trials Market to 2035 | USD 18.7B Growth at 18.2% CAGR

The global Non-Alcoholic Steatohepatitis (NASH) Clinical Trials Market is witnessing rapid expansion, with market value estimated at USD 3.5 billion in 2025 and projected to reach USD 18.7 billion by 2035, growing at a CAGR of 18.2% during the forecast period. Growth is being driven by rising prevalence of obesity, diabetes, and fatty liver disease, increasing investments in liver disease drug...

0 Yorumlar 0 Paylaşımlar 7 Görüntülenme 0 İncelemeler